Partnership announced between Canopy Biosciences – A Bruker Company – and Navinci Diagnostics AB
We are pleased to announce that Navinci’s innovative in situ proximity ligation technology can now be offered by Canopy Biosciences as part of our CRO service lab, enabling more researchers than ever to visualize and quantify proteins, protein-protein interactions and post-translational modifications in situ.